Genetic Analysis operates in medical technology. The company conducts research and development in the field of diagnostics, with the main focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.

Quotes for Genetic Analysis AS

Right Now

+/-
0.014
%
0,77%
Latest
1.84
High
1.842
Low
1.8
Volume
532
Turnover (NOK)
963
Market Value (MNOK)
45,8
Time (Latest trade)

Board

CEO

  • Ronny Hermansen

Chairperson of the Board

  • Per Matsson

Board

  • Andrew Stapleton
  • Camilla Huse Bondesson
  • Rune Sørum
  • Staffan Strömberg

Largest Owners

Name Capital % Votes % Date
Avanza Bank AB 27,73 27,73 2022-12-28
Bio-Rad Luxembourg S.À.R.L. 21,26 21,26 2022-12-28
Nordnet Bank AB 6,20 6,20 2022-12-28
Biohit Oyj 5,71 5,71 2022-12-28
Negma Group Ltd. 4,63 4,63 2021-10-01
Norsk Innovasjonskapital 3,28 3,28 2021-10-01
Molver AS 2,59 2,59 2022-12-28
Leif Jørgen Moger 2,22 2,22 2022-12-28
S. Munkhaugen AS 1,94 1,94 2022-12-28
Jama Holding AS 1,72 1,72 2022-12-28

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2023-05-11 Årsstämma 2022

  • 2023-05-25 Delårsrapport 2023-Q1